KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Non-Current Assets (2016 - 2025)

NovoCure's Other Non-Current Assets history spans 12 years, with the latest figure at $10.6 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 27.51% year-over-year to $10.6 million; the TTM value through Dec 2025 reached $10.6 million, down 27.51%, while the annual FY2025 figure was $10.6 million, 27.51% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $10.6 million at NovoCure, down from $12.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $15.6 million in Q2 2025 and bottomed at $10.6 million in Q4 2025.
  • The 5-year median for Other Non-Current Assets is $12.1 million (2021), against an average of $12.4 million.
  • The largest annual shift saw Other Non-Current Assets soared 123.63% in 2021 before it decreased 27.51% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $12.1 million in 2021, then dropped by 7.65% to $11.2 million in 2022, then grew by 25.63% to $14.0 million in 2023, then increased by 4.25% to $14.6 million in 2024, then dropped by 27.51% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Other Non-Current Assets are $10.6 million (Q4 2025), $12.4 million (Q3 2025), and $15.6 million (Q2 2025).